Clinical Trial Update: A Real-world Study of the Effectiveness of Tisagenlecleucel in Acute Lymphoblastic Leukemia Patients

View source ↗

Summary

This clinical trial update summarizes real-world effectiveness data for tisagenlecleucel in patients with acute lymphoblastic leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• tisagenlecleucel (Kymriah) (tisagenlecleucel)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Acute Lymphoblastic Leukemia | Status: COMPLETED